港通医疗 (301515.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(港通医疗)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度2022年第一季度
上市前/上市后 上市后上市后上市后上市前上市前上市前
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 76,119,952.75408,259,615.8690,410,826.27272,893,090.9170,874,328.7757,225,289.58
 营业收入(元) 76,119,952.75408,259,615.8690,410,826.27272,893,090.9170,874,328.7757,225,289.58
二、营业总成本(元) 77,757,539.66335,553,743.0195,251,510.36235,470,104.0472,631,494.8960,311,139.76
 营业成本(元) 56,998,321.46294,654,578.8568,357,457.12200,392,507.6349,343,088.0341,822,628.49
 研发费用(元) 5,265,641.537,659,599.167,411,786.597,637,951.937,160,670.593,026,020.84
 营业税金及附加(元) 532,684.602,238,451.551,275,447.931,778,291.35588,284.19301,517.98
 销售费用(元) 9,455,099.8919,357,689.8011,222,187.4114,548,733.868,435,424.808,855,812.03
 管理费用(元) 5,892,516.9113,384,620.137,414,005.5310,241,643.786,217,369.365,540,644.05
 财务费用(元) -386,724.73-1,741,196.48-429,374.22870,975.49886,657.92764,516.37
  其中:利息费用(元) -1,103,472.001,082,460.231,089,548.74926,354.03808,292.53
  其中:利息收入(元) -2,956,563.991,662,594.71261,510.28260,095.79157,712.34
 资产减值损失(元) 94,014.69-661,596.98277,123.18-218,790.32-109,512.0345,288.80
 信用减值损失(元) 10,521,209.75-29,948,707.251,049,695.58-14,687,732.387,340,670.534,389,194.90
三、其他经营收益
 加:投资收益(元) 1,360,039.53-----
 资产处置收益(元) -1,583.47-377.51---
 其他收益(元) 281,243.738,552,720.24882,762.911,244,626.871,027,068.27634,290.04
四、营业利润(元) 10,618,920.7951,853,267.63-2,631,479.9341,582,339.486,501,060.651,982,923.56
 加:营业外收入(元) 104,826.79666,532.3222,482.58344,774.5640,178.48184,106.99
 减:营业外支出(元) 27,056.71395,298.202,560,318.86448,701.15108,957.2623,548.73
五、利润总额(元) 10,696,690.8752,124,501.75-5,169,316.2141,478,412.896,432,281.872,143,481.82
 减:所得税费用(元) -10,697.536,839,886.73-673,070.705,267,898.70333,992.46324,737.08
六、净利润(元) 10,707,388.4045,284,615.02-4,496,245.5136,210,514.196,098,289.411,818,744.74
(一)按经营持续性分类
  持续经营净利润(元) 10,707,388.4045,284,615.02-4,496,245.5136,210,514.196,098,289.411,818,744.74
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 10,707,388.4045,284,615.02-4,496,245.5136,210,514.196,098,289.411,818,744.74
 扣除非经常性损益后的净利润(元) 10,445,473.8637,947,683.58-2,705,955.9920,089,863.255,295,600.001,143,100.00
七、每股收益
 一、基本每股收益(元) 0.110.59-0.180.480.080.02
 二、稀释每股收益(元) 0.110.59-0.18---
八、其他综合收益(元) --189,199.82-97,551.16---
 归属于母公司股东的其他综合收益(元) --189,199.82-97,551.16---
九、综合收益总额(元) 10,707,388.4045,095,415.20-4,593,796.6736,033,940.266,098,289.411,818,744.74
 归属于母公司所有者的综合收益总额(元) 10,707,388.4045,095,415.20-4,593,796.6736,033,940.266,098,289.411,818,744.74
公告日期 2024-04-242024-04-242023-10-242023-08-292023-07-032023-07-03
审计意见(境内) 标准无保留意见

前瞻产业研究院